• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FIGS Releases Third Quarter 2025 Financial Results

    11/6/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary
    Get the next $FIGS alert in real time by email

    Exceeded Expectations on Both Top and Bottom Lines

    Grew Net Revenues 8.2%, Strongest Quarterly Growth Rate in Two Years

    Achieved Net Income Margin of 5.8% and Adjusted EBITDA Margin of 12.4%

    Increasing Full Year 2025 Outlook

    FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its third quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/.

    Third Quarter 2025 Financial Highlights

    • Net revenues were $151.7 million, an increase of 8.2% year over year, primarily due to an increase in orders from new and existing customers and higher average order value ("AOV").(1)
      • Scrubwear net revenues were $127.0 million, an increase of 8.4% year over year.
      • Non-scrubwear net revenues were $24.6 million, an increase of 7.2% year over year.
      • U.S. net revenues were $127.3 million, an increase of 7.5% year over year.
      • International net revenues were $24.3 million, an increase of 11.7% year over year.
    • Gross margin was 69.9%, an increase of 280 basis points year over year, primarily due to a lower mix of promotional sales, improved return rates and processing, lower duty rates, and reduced freight expenses, partially offset by higher tariffs.
    • Operating expenses were $96.4 million, a decrease of 6.1% year over year. As a percentage of net revenues, operating expenses decreased to 63.6% from 73.2% in the same period last year, primarily due to lower fulfillment expenses, higher brand marketing expenses last year in conjunction with our Olympics campaign, and lower stock-based compensation expense.
    • Net income was $8.7 million, or $0.05 in diluted earnings per share, compared to net income (loss) of $(1.7) million, or $(0.01) in diluted earnings (loss) per share, in the same period last year.
    • Net income (loss) margin(2) was 5.8%, as compared to (1.2)% in the same period last year.
    • Adjusted EBITDA(3) was $18.9 million, an increase of $14.1 million year over year.
    • Adjusted EBITDA margin(2)(3) was 12.4%, as compared to 3.4% in the same period last year.

    Key Operating Metrics

    • Active customers(1) as of September 30, 2025 increased 4.0% year over year to 2.8 million.
    • Net revenues per active customer(1) were $209, an increase of 2.0% year over year.
    • AOV(1) was $114, an increase of 5.6% year over year, primarily driven by higher average unit retail due to product mix and a higher rate of full-priced sales.

    "FIGS' third quarter was highlighted by top and bottom line results that exceeded our internal expectations, including the strongest revenue growth over the past two years," said Trina Spear, Chief Executive Officer and Co-Founder. "Our diligent work this year to support our community with a great product assortment and impactful brand moments has been instrumental in driving momentum across scrubwear, our U.S. business, and our business-as-usual selling days. Each of these is a key foundational area of our business and a great indicator of our brand health. We are the clear leaders in the space and believe our actions will compound the fundamental drivers of this healthy business over the long term."

    Full Year 2025 Financial Outlook

    Net Revenues growth vs. 2024

    up ~7.0%

     

     

    Adjusted EBITDA Margin(2)(4)

    ~10.3%

    Sarah Oughtred, Chief Financial Officer, commented, "Our year-to-date performance shows we are executing strongly against plan and driving improved consistency across the business. Along with growing confidence in our fourth quarter positioning, we are meaningfully increasing our expectations with full year net revenues now expected to increase approximately 7.0% and adjusted EBITDA margin now expected above the high end of our original outlook despite tariff headwinds. With improving profitability and ample balance sheet flexibility, we believe we are positioned to remain on offense and drive the sustainable growth story we see ahead."

    (1) "Active customers," "net revenues per active customer" and "average order value" are key operational and business metrics that are important to understanding the Company's performance. Please see the sections titled "Non-GAAP Financial Measures and Key Operating Metrics" and "Key Operating Metrics" below for information regarding how the Company calculates its key operational and business metrics and for comparisons of active customers, net revenues per active customer and average order value to the prior year period.
     
    (2) "Net income (loss) margin" and "adjusted EBITDA margin" are calculated by dividing net income (loss) and adjusted EBITDA by net revenues, respectively.
     
    (3) "Adjusted EBITDA" and "adjusted EBITDA margin" are non-GAAP financial measures. Please see the sections titled "Non-GAAP Financial Measures and Key Operating Metrics" and "Reconciliations of GAAP to Non-GAAP Measures" below for more information regarding the Company's use of non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.
     
    (4) The Company has not provided a quantitative reconciliation of its adjusted EBITDA margin outlook to a GAAP net income outlook because it is unable, without making unreasonable efforts, to project certain reconciling items. These items include, but are not limited to, future stock-based compensation expense, income taxes, expenses related to non-ordinary course disputes, and transaction costs. These items are inherently variable and uncertain and depend on various factors, some of which are outside of the Company's control or ability to predict. For more information regarding the Company's use of non-GAAP financial measures, please see the section titled "Non-GAAP Financial Measures and Key Operating Metrics."

    Conference Call Details

    FIGS management will host a conference call and webcast today at 2:00 p.m. PT / 5:00 p.m. ET to discuss the Company's financial and business results and outlook. To participate, please dial 1-833-470-1428 (US) or 1-646-844-6383 (International) and the conference ID 048273. The call is also accessible via webcast at ir.wearfigs.com. A recording will be available shortly after the conclusion of the call until 11:59 p.m. ET on November 13, 2025. To access the replay, please dial 1-866-813-9403 (US) or 1-929-458-6194 (International) and the conference ID 438713. An archive of the webcast will be available on FIGS' investor relations website at ir.wearfigs.com.

    Non-GAAP Financial Measures and Key Operating Metrics

    In addition to the GAAP financial measures set forth in this press release, the Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K. The Company uses "adjusted EBITDA" and "adjusted EBITDA margin" to provide useful supplemental measures that assist in evaluating its ability to generate earnings, provide consistency and comparability with its past financial performance and facilitate period-to-period comparisons of its core operating results as well as the results of its peer companies. The Company uses "free cash flow" as a useful supplemental measure of liquidity and as an additional basis for assessing its ability to generate cash. The Company calculates "adjusted EBITDA" as net income (loss) adjusted to exclude: other income, net; gain/loss on disposal of assets; provision for income taxes; depreciation and amortization expense; stock-based compensation and related expense; transaction costs; and expenses related to non-ordinary course disputes. The Company calculates "adjusted EBITDA margin" by dividing adjusted EBITDA by net revenues. The Company calculates "free cash flow" as net cash (used in) provided by operating activities reduced by capital expenditures, including purchases of property and equipment and capitalized software development costs.

    Reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures are included below under the heading "Reconciliations of GAAP to Non-GAAP Measures."

    The Company has also included herein "active customers," "net revenues per active customer" and "average order value," which are key operational and business metrics that are important to understanding Company performance. The Company believes the number of active customers is an important indicator of growth as it reflects the reach of the Company's digital platform, brand awareness and overall value proposition. The Company defines an active customer as a unique customer account that has made at least one purchase in the preceding 12-month period. In any particular period, the Company determines the number of active customers by counting the total number of customers who have made at least one purchase in the preceding 12-month period, measured from the last date of such period. The Company believes measuring net revenues per active customer is important to understanding engagement and retention of customers, and as such, the value proposition for its customer base. The Company defines net revenues per active customer as the sum of total net revenues in the preceding 12-month period divided by the current period active customers. The Company defines average order value as the sum of the total net revenues in a given period divided by the total orders placed in that period. Total orders are the summation of all completed individual purchase transactions in a given period. The Company believes its relatively high average order value demonstrates the premium nature of its products. As the Company expands into and increases its presence in additional product categories, price points and international markets, average order value may fluctuate.

    Active customers as of September 30, 2025 and 2024, respectively, net revenues per active customer as of September 30, 2025 and 2024, respectively, and average order value for the three and nine months ended September 30, 2025 and 2024, respectively, are presented below under the heading "Key Operating Metrics."

    About FIGS

    FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower, and serve current and future generations of healthcare professionals. We create technically advanced apparel and products that feature an unmatched combination of comfort, durability, function, and style. We share stories about healthcare professionals' experiences in ways that inspire them. We build meaningful connections within the healthcare community that we created. Above all, we seek to make an impact for our community, including by advocating for them and always having their backs.

    We serve healthcare professionals both in the U.S. and internationally. We also serve healthcare institutions through our TEAMS platform.

    Forward-Looking Statements

    This press release contains various forward-looking statements about the Company within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are based on current management expectations, and which involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, such forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking. These forward-looking statements generally are identified by the words "anticipate", "believe", "contemplate", "continue", "could", "estimate", "expect", "forecast", "future", "intend", "may", "might", "opportunity", "outlook", "plan", "possible", "potential", "predict", "project," "should", "strategy", "strive", "target", "will" or "would", the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. These forward-looking statements address various matters, including the Company's belief that its actions will compound the fundamental drivers of the business over the long term; the Company's growing confidence in its fourth quarter positioning; the Company's belief that it is positioned to drive sustainable growth; and the information under the section titled "Full Year 2025 Financial Outlook," such as the Company's outlook as to net revenues growth and adjusted EBITDA margin for the full year ending December 31, 2025; all of which reflect the Company's expectations based upon currently available information and data. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, the Company's actual results, performance or achievements may differ materially from those expressed or implied by the forward-looking statements, and you are cautioned not to place undue reliance on these forward-looking statements. The following important factors and uncertainties, among others, could cause actual results, performance or achievements to differ materially from those described in these forward-looking statements: the Company's ability to maintain its historical growth; the Company's ability to maintain profitability; the Company's ability to maintain the value and reputation of its brand; the Company's ability to attract new customers, retain existing customers, and to maintain or increase sales to those customers; the success of the Company's marketing efforts; the Company's ability to maintain a strong community of engaged customers and Ambassadors; negative publicity related to the Company's marketing efforts or use of social media; the Company's ability to successfully develop and introduce new, innovative and updated products; the competitiveness of the market for healthcare apparel; the Company's ability to maintain its key employees; the Company's ability to attract and retain highly skilled team members; risks associated with expansion into, and conducting business in, international markets; changes in, or disruptions to, the Company's shipping arrangements; the successful operation of the Company's fulfillment operations; the Company's ability to accurately forecast customer demand, manage its inventory, and plan for future expenses; the impact of changes in consumer confidence, shopping behavior and consumer spending on demand for the Company's products; the impact of macroeconomic trends on the Company's operations; the Company's reliance on a limited number of third-party suppliers; the impact of global trade policy on the Company's ability to source and distribute its products; the fluctuating costs of raw materials; the Company's ability to execute on its B2B growth strategy; the Company's ability to execute on its retail growth strategy; the Company's failure to protect proprietary, confidential or sensitive information or personal customer data, or risks of cyberattacks; the Company's failure to protect its intellectual property rights; the fact that the operations of many of the Company's suppliers and vendors are subject to additional risks that are beyond its control; and other risks, uncertainties and factors discussed in the "Risk Factors" section of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 to be filed with the Securities and Exchange Commission ("SEC"), the Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 27, 2025, and the Company's other periodic filings with the SEC. The forward-looking statements in this press release speak only as of the time made and the Company does not undertake to update or revise them to reflect future events or circumstances.

    FIGS, INC.

     

    CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

     

     

    As of

     

    September 30,

    2025

     

    December 31,

    2024

    Assets

    (Unaudited)

     

     

    Current assets

     

     

     

    Cash and cash equivalents

    $

    46,454

     

    $

    85,645

    Short-term investments

     

    195,072

     

     

     

    159,469

     

    Accounts receivable

     

    12,218

     

     

     

    8,625

     

    Inventory, net

     

    151,233

     

     

     

    115,759

     

    Prepaid expenses and other current assets

     

    13,041

     

     

     

    13,268

     

    Total current assets

     

    418,018

     

     

     

    382,766

     

    Non-current assets

     

     

     

    Property and equipment, net

     

    33,565

     

     

     

    35,274

     

    Operating lease right-of-use assets

     

    50,689

     

     

     

    50,497

     

    Deferred tax assets

     

    13,098

     

     

     

    11,643

     

    Investment in equity securities

     

    27,735

     

     

     

    27,534

     

    Other assets

     

    1,633

     

     

     

    2,073

     

    Total non-current assets

     

    126,720

     

     

     

    127,021

     

    Total assets

    $

    544,738

     

     

    $

    509,787

     

    Liabilities and stockholders' equity

     

     

     

    Current liabilities

     

     

     

    Accounts payable

    $

    5,345

     

     

    $

    9,401

     

    Operating lease liabilities

     

    9,448

     

     

     

    10,596

     

    Accrued expenses

     

    34,189

     

     

     

    42,316

     

    Accrued compensation and benefits

     

    12,404

     

     

     

    5,689

     

    Sales tax payable

     

    3,730

     

     

     

    3,705

     

    Gift card liability

     

    10,018

     

     

     

    9,604

     

    Deferred revenue

     

    8,308

     

     

     

    4,612

     

    Returns reserve

     

    3,217

     

     

     

    3,873

     

    Income tax payable

     

    —

     

     

     

    346

     

    Total current liabilities

     

    86,659

     

     

     

    90,142

     

    Non-current liabilities

     

     

     

    Operating lease liabilities, non-current

     

    44,667

     

     

     

    42,430

     

    Other non-current liabilities

     

    83

     

     

     

    83

     

    Total liabilities

     

    131,409

     

     

     

    132,655

     

    Commitments and contingencies

     

     

     

    Stockholders' equity

     

     

     

    Class A common stock — par value $0.0001 per share, 1,000,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 155,873,752 and 154,003,352 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

     

    15

     

     

     

    15

     

    Class B common stock — par value $0.0001 per share, 150,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 8,283,641 shares issued and outstanding as of September 30, 2025 and December 31, 2024

     

    —

     

     

     

    —

     

    Preferred stock — par value $0.0001 per share, 100,000,000 shares authorized as of September 30, 2025 and December 31, 2024; zero shares issued and outstanding as of September 30, 2025 and December 31, 2024

     

    —

     

     

     

    —

     

    Additional paid-in capital

     

    332,935

     

     

     

    312,622

     

    Accumulated other comprehensive income

     

    162

     

     

     

    21

     

    Retained earnings

     

    80,217

     

     

     

    64,474

     

    Total stockholders' equity

     

    413,329

     

     

     

    377,132

     

    Total liabilities and stockholders' equity

    $

    544,738

     

     

    $

    509,787

     

    FIGS, INC.

     

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three months ended

    September 30,

     

    Nine months ended

    September 30,

     

    2025

     

    2024

     

    2025

     

    2024

    Net revenues

    $

    151,661

     

    $

    140,209

     

     

    $

    429,202

     

    $

    403,726

     

    Cost of goods sold

     

    45,593

     

     

     

    46,181

     

     

     

    136,429

     

     

     

    130,299

     

    Gross profit

     

    106,068

     

     

     

    94,028

     

     

     

    292,773

     

     

     

    273,427

     

    Operating expenses

     

     

     

     

     

     

     

    Selling

     

    35,841

     

     

     

    38,599

     

     

     

    102,952

     

     

     

    103,992

     

    Marketing

     

    23,472

     

     

     

    28,529

     

     

     

    64,779

     

     

     

    68,778

     

    General and administrative

     

    37,120

     

     

     

    35,529

     

     

     

    105,703

     

     

     

    107,292

     

    Total operating expenses

     

    96,433

     

     

     

    102,657

     

     

     

    273,434

     

     

     

    280,062

     

    Net income (loss) from operations

     

    9,635

     

     

     

    (8,629

    )

     

     

    19,339

     

     

     

    (6,635

    )

    Other income, net

     

     

     

     

     

     

     

    Interest income

     

    2,315

     

     

     

    2,926

     

     

     

    6,510

     

     

     

    8,603

     

    Other income (expense)

     

    9

     

     

     

    2

     

     

     

    5

     

     

     

    (8

    )

    Total other income, net

     

    2,324

     

     

     

    2,928

     

     

     

    6,515

     

     

     

    8,595

     

    Net income (loss) before provision (benefit) for income taxes

     

    11,959

     

     

     

    (5,701

    )

     

     

    25,854

     

     

     

    1,960

     

    Provision (benefit) for income taxes

     

    3,213

     

     

     

    (4,001

    )

     

     

    10,111

     

     

     

    1,125

     

    Net income (loss)

    $

    8,746

     

     

    $

    (1,700

    )

     

    $

    15,743

     

     

    $

    835

     

    Earnings attributable to Class A and Class B common stockholders

     

     

     

     

     

     

     

    Basic earnings (loss) per share

    $

    0.05

     

     

    $

    (0.01

    )

     

    $

    0.10

     

     

    $

    —

     

    Diluted earnings (loss) per share

    $

    0.05

     

     

    $

    (0.01

    )

     

    $

    0.09

     

     

    $

    —

     

    Weighted-average shares outstanding—basic

     

    163,665,566

     

     

     

    170,168,732

     

     

     

    162,942,689

     

     

     

    170,161,922

     

    Weighted-average shares outstanding—diluted

     

    180,875,933

     

     

     

    170,168,732

     

     

     

    175,974,151

     

     

     

    180,614,560

     

    FIGS, INC.

     

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)

     

     

    Nine months ended

    September 30,

     

    2025

     

    2024

    Cash flows from operating activities:

     

     

     

    Net income

    $

    15,743

     

     

    $

    835

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

    Depreciation and amortization expense

     

    6,478

     

     

     

    4,848

     

    Deferred income taxes

     

    (1,455

    )

     

     

    421

     

    Non-cash operating lease cost

     

    7,382

     

     

     

    6,211

     

    Stock-based compensation

     

    21,683

     

     

     

    32,618

     

    Accretion of discount and accrued interest on available-for-sale securities

     

    (2,981

    )

     

     

    (4,720

    )

    Changes in operating assets and liabilities:

     

     

     

    Accounts receivable

     

    (3,517

    )

     

     

    (3,030

    )

    Inventory

     

    (35,474

    )

     

     

    (4,356

    )

    Prepaid expenses and other current assets

     

    227

     

     

     

    (7,965

    )

    Other assets

     

    440

     

     

     

    (824

    )

    Accounts payable

     

    (4,018

    )

     

     

    10,828

     

    Accrued expenses

     

    (7,629

    )

     

     

    21,231

     

    Accrued compensation and benefits

     

    6,715

     

     

     

    (1,905

    )

    Sales tax payable

     

    25

     

     

     

    1,101

     

    Gift card liability

     

    414

     

     

     

    (296

    )

    Deferred revenue

     

    3,696

     

     

     

    1,723

     

    Returns reserve

     

    (656

    )

     

     

    1,643

     

    Income tax payable

     

    (346

    )

     

     

    (2,212

    )

    Operating lease liabilities

     

    (6,485

    )

     

     

    (5,405

    )

    Net cash provided by operating activities

     

    242

     

     

     

    50,746

     

    Cash flows from investing activities:

     

     

     

    Purchases of property and equipment

     

    (5,305

    )

     

     

    (13,658

    )

    Purchases of available-for-sale securities

     

    (185,857

    )

     

     

    (191,379

    )

    Maturities of available-for-sale securities

     

    153,300

     

     

     

    141,230

     

    Other investing activities

     

    (201

    )

     

     

    —

     

    Net cash used in investing activities

     

    (38,063

    )

     

     

    (63,807

    )

    Cash flows from financing activities:

     

     

     

    Repurchases of Class A Common Stock

     

    (2,688

    )

     

     

    (7,277

    )

    Proceeds from stock option exercises and employee stock purchases

     

    1,318

     

     

     

    268

     

    Net cash used in financing activities

     

    (1,370

    )

     

     

    (7,009

    )

    Net change in cash and cash equivalents

     

    (39,191

    )

     

     

    (20,070

    )

    Cash and cash equivalents beginning of period

    $

    85,645

     

     

    $

    144,173

     

    Cash and cash equivalents end of period

    $

    46,454

     

     

    $

    124,103

     

    FIGS, INC.

     

    RECONCILIATIONS OF GAAP TO NON-GAAP MEASURES

    (Unaudited)

     

    The following table presents a reconciliation of adjusted EBITDA to net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP, and presents adjusted EBITDA margin with net income (loss) margin, which is the most directly comparable financial measure calculated in accordance with GAAP:

     

     

    Three months ended

    September 30,

     

    Nine months ended

    September 30,

     

    2025

     

    2024

     

    2025

     

    2024

     

    (in thousands, except margin)

    Net income (loss)

    $

    8,746

     

     

    $

    (1,700

    )

     

    $

    15,743

     

     

    $

    835

     

    Add (deduct):

     

     

     

     

     

     

     

    Other income, net

     

    (2,324

    )

     

     

    (2,928

    )

     

     

    (6,515

    )

     

     

    (8,595

    )

    Provision (benefit) for income taxes

     

    3,213

     

     

     

    (4,001

    )

     

     

    10,111

     

     

     

    1,125

     

    Depreciation and amortization expense(1)

     

    2,327

     

     

     

    2,885

     

     

     

    6,478

     

     

     

    4,848

     

    Stock-based compensation and related expense(2)

     

    6,889

     

     

     

    10,544

     

     

     

    21,935

     

     

     

    32,506

     

    Adjusted EBITDA(3)

    $

    18,851

     

     

    $

    4,800

     

     

    $

    47,752

     

     

    $

    30,719

     

     

     

     

     

     

     

     

     

    Net revenues

    $

    151,661

     

     

    $

    140,209

     

     

    $

    429,202

     

     

    $

    403,726

     

    Net income (loss) margin(4)

     

    5.8

    %

     

     

    (1.2

    )%

     

     

    3.7

    %

     

     

    0.2

    %

    Adjusted EBITDA Margin

     

    12.4

    %

     

     

    3.4

    %

     

     

    11.1

    %

     

     

    7.6

    %

     

    (1) Excludes amortization of debt issuance costs included in "Other income, net."

     

    (2) Includes stock-based compensation expense, payroll taxes, and costs related to equity award activity.

     

    (3) For the nine months ended September 30, 2025, reflects $171,000 of stock-based compensation expense and payroll taxes inadvertently not reflected in our previously disclosed Adjusted EBITDA results for the three months ended March 31, 2025.

     

    (4) Net income (loss) margin represents net income (loss) as a percentage of net revenues.

    The following table presents a reconciliation of free cash flow to net cash provided by operating activities, which is the most directly comparable financial measure calculated in accordance with GAAP:

     

     

    Nine months ended

    September 30,

     

    2025

     

    2024

     

    (in thousands)

    Net cash provided by operating activities

    $

    242

     

     

    $

    50,746

     

    Less: capital expenditures

     

    (5,305

    )

     

     

    (13,658

    )

    Free cash flow

    $

    (5,063

    )

     

    $

    37,088

     

    FIGS, INC.

     

    KEY OPERATING METRICS

    (Unaudited)

     

    Active customers as of September 30, 2025 and 2024, respectively, net revenues per active customer as of September 30, 2025 and 2024, respectively, and average order value for the three and nine months ended September 30, 2025 and 2024, respectively, are presented in the following tables:

     

     

    As of September 30,

     

    2025

     

    2024

     

    (in thousands)

    Active customers

    2,781

     

    2,673

     

    As of September 30,

     

    2025

     

    2024

    Net revenues per active customer

    $

    209

     

    $

    205

     

    Three months ended

    September 30,

     

    Nine months ended

    September 30,

     

    2025

     

    2024

     

    2025

     

    2024

    Average order value

    $

    114

     

    $

    108

     

    $

    117

     

    $

    112

    FIGS, INC.

     

    DISAGGREGATED NET REVENUES

    (In thousands, except percentages)

    (Unaudited)

     

    The following table presents the disaggregation of the Company's net revenues for the three and nine months ended September 30, 2025 and September 30, 2024:

     

     

    Three months ended

    September 30,

     

    Change

     

    Nine months ended

    September 30,

     

    Change

     

    2025

     

    2024

     

    %

     

    2025

     

    2024

     

    %

    By geography:

     

     

     

     

     

     

     

     

     

     

     

    United States

    $

    127,343

     

    $

    118,441

     

    7.5%

     

    $

    363,310

     

    $

    346,801

     

    4.8%

    Rest of the world

     

    24,318

     

     

     

    21,768

     

     

    11.7%

     

     

    65,892

     

     

     

    56,925

     

     

    15.8%

     

    $

    151,661

     

     

    $

    140,209

     

     

    8.2%

     

    $

    429,202

     

     

    $

    403,726

     

     

    6.3%

    By product:

     

     

     

     

     

     

     

     

     

     

     

    Scrubwear

    $

    127,015

     

     

    $

    117,219

     

     

    8.4%

     

    $

    353,999

     

     

    $

    330,459

     

     

    7.1%

    Non-Scrubwear

     

    24,646

     

     

     

    22,990

     

     

    7.2%

     

     

    75,203

     

     

     

    73,267

     

     

    2.6%

     

    $

    151,661

     

     

    $

    140,209

     

     

    8.2%

     

    $

    429,202

     

     

    $

    403,726

     

     

    6.3%

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251106894550/en/

    Investors:

    Tom Shaw

    [email protected]

    Media:

    Todd Maron

    [email protected]

    Get the next $FIGS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FIGS

    DatePrice TargetRatingAnalyst
    11/7/2025$7.00 → $9.00Market Perform
    Telsey Advisory Group
    10/15/2025$9.00Buy
    BTIG Research
    8/8/2025$5.00 → $7.00Market Perform
    Telsey Advisory Group
    5/5/2025$7.00 → $5.00Market Perform
    Telsey Advisory Group
    8/9/2024$6.00 → $7.00Market Perform
    Telsey Advisory Group
    4/2/2024$8.50 → $4.50Neutral → Underperform
    BofA Securities
    3/8/2024Outperform → Perform
    Oppenheimer
    2/29/2024$6.00Outperform → Market Perform
    Telsey Advisory Group
    More analyst ratings

    $FIGS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Oughtred Sarah sold $168,015 worth of shares (22,745 units at $7.39), decreasing direct ownership by 3% to 845,345 units (SEC Form 4)

    4 - FIGS, Inc. (0001846576) (Issuer)

    11/6/25 6:09:26 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Executive Chair Hasson Heather L. sold $172,528 worth of shares (23,356 units at $7.39), decreasing direct ownership by 2% to 1,274,841 units (SEC Form 4)

    4 - FIGS, Inc. (0001846576) (Issuer)

    11/6/25 6:04:37 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Chief Financial Officer Oughtred Sarah sold $73,364 worth of shares (9,968 units at $7.36), decreasing direct ownership by 1% to 868,090 units (SEC Form 4)

    4 - FIGS, Inc. (0001846576) (Issuer)

    10/6/25 6:46:16 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FIGS Releases Third Quarter 2025 Financial Results

    Exceeded Expectations on Both Top and Bottom Lines Grew Net Revenues 8.2%, Strongest Quarterly Growth Rate in Two Years Achieved Net Income Margin of 5.8% and Adjusted EBITDA Margin of 12.4% Increasing Full Year 2025 Outlook FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its third quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Third Quarter 2025 Financial Highlights Net revenues were $151.7 million, an increase of 8.2% year over year, primarily due to an i

    11/6/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS First-Ever Brand to Outfit the Team USA Medical Team at an Olympic and Paralympic Winter Games

    FIGS' celebration of the Team USA Medical Team will take place at the Olympic and Paralympic Winter Games Milano Cortina 2026 FIGS (NYSE:FIGS), the leading global healthcare apparel brand, today announced that its partnership with Team USA will include outfitting 150+ healthcare professionals on the ground at the Milano Cortina 2026 Olympic and Paralympic Winter Games. This marks the first time the Team USA Medical Team will be outfitted at a Winter Games. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029946723/en/ Building on its successful multi-year partnership with the United States Olympic & Paralympic Committee (USOP

    10/29/25 9:00:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Announces Date of Third Quarter 2025 Earnings Release, Conference Call and Webcast

    FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a third quarter 2025 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx. FIGS Third Quarter 2025 Earnings and Conference Call Date: Thursday, November 6, 2025 Time: 2:

    10/16/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    SEC Filings

    View All

    SEC Form 10-Q filed by FIGS Inc.

    10-Q - FIGS, Inc. (0001846576) (Filer)

    11/6/25 4:24:23 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FIGS, Inc. (0001846576) (Filer)

    11/6/25 4:13:59 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    SEC Form 144 filed by FIGS Inc.

    144 - FIGS, Inc. (0001846576) (Subject)

    11/4/25 8:54:42 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on FIGS, Inc. with a new price target

    Telsey Advisory Group reiterated coverage of FIGS, Inc. with a rating of Market Perform and set a new price target of $9.00 from $7.00 previously

    11/7/25 7:47:45 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    BTIG Research initiated coverage on FIGS, Inc. with a new price target

    BTIG Research initiated coverage of FIGS, Inc. with a rating of Buy and set a new price target of $9.00

    10/15/25 8:28:19 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on FIGS, Inc. with a new price target

    Telsey Advisory Group reiterated coverage of FIGS, Inc. with a rating of Market Perform and set a new price target of $7.00 from $5.00 previously

    8/8/25 7:49:08 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Leadership Updates

    Live Leadership Updates

    View All

    FIGS Adds Digital Marketing Executive Jerry Jao as New Independent Director to Its Board of Directors

    FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Jerry Jao, former Chief Executive Officer of Retention Science, to its board of directors (the "Board"), effective April 1, 2025 (the "Effective Date"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250403714974/en/Jerry Jao Mr. Jao joins the Board as an independent director and has also been appointed to serve as both Chair of the Board's Audit Committee and as a member of the Board's Compensation Committee. Since May 2024, Mario Marte has served as

    4/3/25 8:00:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Announces Updates to Board of Directors

    FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Melanie Whelan, former Chief Executive Officer of SoulCycle Inc., to its board of directors (the "Board"), effective January 1, 2025 (the "Effective Date"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241219372097/en/Melanie Whelan (Photo: Business Wire) Ms. Whelan joins the Board as an independent director. Ms. Whelan has also been appointed to serve as Chair of the Board's Compensation Committee, which as of the Effective Date will consist of Ms.

    12/19/24 6:50:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Sarah Oughtred to Become FIGS' New Chief Financial Officer

    Longtime Senior Finance Executive Joins FIGS After Almost 17 Years at lululemon FIGS, Inc. (NYSE:FIGS), the renowned medical apparel brand, today announced the appointment of Sarah Oughtred as the Company's new Chief Financial Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240612619238/en/(Photo: Business Wire) To facilitate a smooth transition, Ms. Oughtred will join FIGS on July 29, 2024, and will become FIGS' Chief Financial Officer, effective August 9, 2024. Ms. Oughtred will lead all aspects of finance, including FP&A and accounting, and will also lead data analytics. "I am thrilled to welcome Sarah to FIGS dur

    6/12/24 6:50:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by FIGS Inc.

    SC 13G/A - FIGS, Inc. (0001846576) (Subject)

    11/14/24 1:28:33 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    SEC Form SC 13G filed by FIGS Inc.

    SC 13G - FIGS, Inc. (0001846576) (Subject)

    11/14/24 12:17:49 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by FIGS Inc.

    SC 13G/A - FIGS, Inc. (0001846576) (Subject)

    11/13/24 10:27:59 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Financials

    Live finance-specific insights

    View All

    FIGS Releases Third Quarter 2025 Financial Results

    Exceeded Expectations on Both Top and Bottom Lines Grew Net Revenues 8.2%, Strongest Quarterly Growth Rate in Two Years Achieved Net Income Margin of 5.8% and Adjusted EBITDA Margin of 12.4% Increasing Full Year 2025 Outlook FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its third quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Third Quarter 2025 Financial Highlights Net revenues were $151.7 million, an increase of 8.2% year over year, primarily due to an i

    11/6/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Announces Date of Third Quarter 2025 Earnings Release, Conference Call and Webcast

    FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a third quarter 2025 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx. FIGS Third Quarter 2025 Earnings and Conference Call Date: Thursday, November 6, 2025 Time: 2:

    10/16/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Releases Second Quarter 2025 Financial Results

    Exceeded Expectations on Both Top and Bottom Lines Grew Net Revenues 5.8% Achieved Net Income Margin of 4.7% and Adjusted EBITDA Margin of 12.9% Increasing Full Year 2025 Outlook FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its second quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Second Quarter 2025 Financial Highlights Net revenues were $152.6 million, an increase of 5.8% year over year, primarily due to an increase in orders from new and existin

    8/7/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary